Literature DB >> 32530584

Natural History of Asymptomatic SARS-CoV-2 Infection.

Aki Sakurai1, Toshiharu Sasaki1, Shigeo Kato2, Masamichi Hayashi1, Sei-Ichiro Tsuzuki1, Takuma Ishihara3, Mitsunaga Iwata4, Zenichi Morise4, Yohei Doi4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32530584      PMCID: PMC7304419          DOI: 10.1056/NEJMc2013020

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
To the Editor: Information on the natural history of asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains scarce.[1-3] The outbreak of coronavirus disease 2019 (Covid-19) on the cruise ship Diamond Princess led to 712 persons being infected with SARS-CoV-2 among the 3711 passengers and crew members, and 410 (58%) of these infected persons were asymptomatic at the time of testing (see the Supplementary Appendix, available with the full text of this letter at NEJM.org).[4,5] Here, we report the natural history of asymptomatic SARS-CoV-2 infection in part of this cohort. A total of 96 persons infected with SARS-CoV-2 who were asymptomatic at the time of testing, along with their 32 cabinmates who tested negative on the ship, were transferred from the Diamond Princess to a hospital in central Japan between February 19 and February 26 for continued observation. Clinical signs and symptoms of Covid-19 subsequently developed in 11 of these 96 persons, a median of 4 days (interquartile range, 3 to 5; range, 3 to 7) after the first positive polymerase-chain-reaction (PCR) test, which meant that they had been presymptomatic rather than asymptomatic. The risk of being presymptomatic increased with increasing age (odds ratio for being presymptomatic with each 1-year increase in age, 1.08; 95% confidence interval [CI], 1.01 to 1.16). Eight of 32 cabinmates with a negative PCR test on the ship had a positive PCR test within 72 hours after arrival in the hospital but remained asymptomatic. In total, data on 90 persons with asymptomatic SARS-CoV-2 infection, defined as persons who were asymptomatic at the time of the positive PCR test and remained so until the resolution of infection (as determined by two consecutive negative PCR tests), were available for analysis (Fig. S1 in the Supplementary Appendix). The group of persons with asymptomatic SARS-CoV-2 infection consisted of 58 passengers and 32 crew members, with median age of 59.5 years (interquartile range, 36 to 68; range, 9 to 77). A total of 24 of these persons (27%) had coexisting medical conditions, including hypertension (in 20%) and diabetes (9%). The first PCR test at the hospital was performed a mean of 6 days after the initial positive PCR test on the ship. The median number of days between the first positive PCR test (either on the ship or at the hospital) and the first of the two serial negative PCR tests was 9 days (interquartile range, 6 to 11; range, 3 to 21), and the cumulative percentages of persons with resolution of infection 8 and 15 days after the first positive PCR test were 48% and 90%, respectively. The risk of delayed resolution of infection increased with increasing age (mean delay in resolution for an increase in age from 36 to 68 years, 4.41 days; 95% CI, 2.28 to 6.53) (Figure 1).
Figure 1

Crossing-Point Values in RT-PCR Testing of Asymptomatic Persons with SARS-CoV-2 Infection.

Included in the analysis are persons who had at least one positive polymerase-chain-reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the hospital. With fluorescence-based real-time reverse-transcriptase PCR (RT-PCR), the number of cycles at which the fluorescence signal from amplification exceeds the background fluorescence level is determined as the crossing point (Cp), threshold cycle, or other measures by different instrument manufacturers. A lower value correlates with a higher copy number of the target nucleotide sequence.

In this cohort, the majority of asymptomatically infected persons remained asymptomatic throughout the course of the infection. The time to the resolution of infection increased with increasing age.
  92 in total

1.  [Monitoring of the rehabilitation therapy of COVID-19 effort dyspnea].

Authors:  Lucia Ros Dopico; Yale Tung-Chen; Martín Pilares Barco; Ana Muñoz Garcia
Journal:  Enferm Infecc Microbiol Clin       Date:  2020-09-08       Impact factor: 1.731

Review 2.  Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.

Authors:  Kanza N Qaiser; James E Lane; Adriano R Tonelli
Journal:  Pulm Circ       Date:  2020-09-16       Impact factor: 3.017

Review 3.  Mechanistic Modeling of SARS-CoV-2 and Other Infectious Diseases and the Effects of Therapeutics.

Authors:  Alan S Perelson; Ruian Ke
Journal:  Clin Pharmacol Ther       Date:  2021-03-08       Impact factor: 6.875

4.  COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis.

Authors:  Mohapradeep Mohan; Benjamin Ian Perry; Ponnusamy Saravanan; Swaran Preet Singh
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

5.  Synthesis of dual-phase Ti3O5/Ti4O7 nanofibers for efficient adsorption of SARS-CoV-2.

Authors:  Zhanlin Ding; Hong Wang; Zhe Feng; Meiqing Sun
Journal:  Mater Lett       Date:  2021-06-02       Impact factor: 3.423

6.  Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021.

Authors:  Eunha Shim
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

7.  Positive Predictive Value of ICD-10 Diagnosis Codes for COVID-19.

Authors:  Jacob Bodilsen; Steffen Leth; Stig Lønberg Nielsen; Jon Gitz Holler; Thomas Benfield; Lars Haukali Omland
Journal:  Clin Epidemiol       Date:  2021-05-25       Impact factor: 4.790

8.  In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.

Authors:  Ruian Ke; Carolin Zitzmann; David D Ho; Ruy M Ribeiro; Alan S Perelson
Journal:  medRxiv       Date:  2021-06-30

9.  A COVID-19 Exposure at a Dental Clinic Where Healthcare Workers Routinely Use Particulate Filtering Respirators.

Authors:  Dosup Kim; Jae-Hoon Ko; Kyong Ran Peck; Jin Yang Baek; Hee-Won Moon; Hyun Kyun Ki; Ji Hyun Yoon; Hyo Jin Kim; Jeong Hwa Choi; Ga Eun Park
Journal:  Int J Environ Res Public Health       Date:  2021-06-16       Impact factor: 3.390

10.  Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.

Authors:  Shengding Zhang; Wenxue Bai; Junqing Yue; Lu Qin; Cong Zhang; Shuyun Xu; Xiansheng Liu; Wang Ni; Min Xie
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.